FMF patient with Muscle Pain. Soad Haj Yahia Sheba Medical Center Tel Hashomer -Israel

Similar documents
FAMILIAL MEDITERRANEAN FEVER (FMF) RAKAN TELFAH not MD, not PHD

Familial Mediterranean Fever

Familial Mediterranean Fever. By:Ismaeel Qattam

Familial Mediterranean Fever

Familial Mediterranean Fever

Elements for a Public Summary. Overview of disease epidemiology

Cases from the Clinic Maryland ACP Meeting January 30, 2016

Azathioprine toxicity criteria and severity descriptors for the listing of biological agents for rheumatoid arthritis on the PBS

TNF Receptor Associated Periodic Syndrome (TRAPS)

YES NO UNKNOWN. Stage I: Rule-Out Dashboard Secondary Findings in Adults ACTIONABILITY PENETRANCE SIGNIFICANCE/BURDEN OF DISEASE NEXT STEPS

Prescribing Information

CASE A 58-year-old woman, office worker CC : fatigue and weakness

THE CLATTERBRIDGE CANCER CENTRE NHS FOUNDATION TRUST. Systemic Anti Cancer Treatment Protocol. Tivozanib. PROTOCOL REF: MPHATIVOUR (Version No: 1.

Treatment monitoring protocol for Dimethyl fumarate therapy in active Relapsing Remitting Multiple Sclerosis

Case report. Yasutsugu Fukushima, 1 Kazuki Obara, 1 Hirokuni Hirata, 1 Kumiya Sugiyama, 1 Takeshi Fukuda 1 and Kazuhiko Takabe 2

Clinical features. Abnormal vasculogenesis and angiogenesis and releasing of antiangiogenic

BC Cancer Protocol for Treatment of Platinum Resistant Epithelial Ovarian Cancer with Bevacizumab and PACLitaxel

Lung Pathway Group Cisplatin & IV Vinorelbine in Non- Small Cell Lung Cancer (NSCLC)

CASE-BASED SMALL GROUP DISCUSSION MHD II

Adams Memorial Hospital Decatur, Indiana EXPLANATION OF LABORATORY TESTS

EXERTIONAL RHABDOMYOLYSIS. Jeffrey m mjaanes md, facsm

Blood Test Results Report

RHABDOMYOLYSIS AFTER ADDITION OF DIGITOXIN TO CHRONIC SIMVASTATIN AND AMIODARONE THERAPY

Lung Pathway Group Cisplatin & PO Vinorelbine in Non- Small Cell Lung Cancer (NSCLC)

Summary of Product Characteristics

Supplementary Appendix

RAPIDLY FAILING KIDNEYS. Dr Paul Johny 2 nd yr DNB Medicine Resident

Severe falciparum malaria with hypophosphataemia and presumed hypophosphatemia induced rhabdomyolysis: a case report

Breast Pathway Group EC x 4 Docetaxel x 4: Epirubicin & Cyclophosphamide followed by Docetaxel in Early Breast Cancer

ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI CLINICAL RESEARCH CENTER ALDO E FOR CELE RARE DACCO DISEASES ALDO E CELE DACCO

Definition : Stages : ( RIFLE vs. AKIN ) Causes and classification : Pre-renal Renal Post- renal Clinical manifestations and Complication Management

MANAGEMENT OF DENGUE INFECTION IN ADULTS (Revised 2 nd Edition) QUICK REFERENCE FOR HEALTHCARE PROVIDERS

UNIT VI: ACID BASE IMBALANCE

Lung Pathway Group Carboplatin & PO Vinorelbine in Non-Small Cell Lung Cancer (NSCLC)

EMILOK Global. (omeprazole) Composition: Each capsule contains 20 mg omeprazole as enteric-coated

KEY MESSAGES. There are three phases in dengue infection-febrile phase, critical phase and recovery (reabsorption) phase.

SAFETY CONSIDERATIONS WITH YONDELIS (trabectedin)

DOSING AND ADMINISTRATION GUIDE

M0BCore Safety Profile

Exertional Rhabdomyolysis. Christopher A. Gee, MD, MPH, FACEP Department of Orthopaedics University of Utah

Elements for a public summary

2/23/18. Disclosures. Rheumatic Diseases of Childhood. Making Room for Rheumatology. I have nothing to disclose. James J.

INVESTIGATION OF ADVERSE TRANSFUSION REACTIONS TABLE OF RECOMMENDED TESTS. Type of Reaction Presentation Recommended Tests Follow-up Tests

NEW HEMATOLOGY PARAMETERS

Familial Mediterranean fever

One problem above the diaphragm and one problem below the diaphragm

BC Cancer Protocol Summary for Treatment of Platinum Resistant Epithelial Ovarian Cancer with Bevacizumab and Vinorelbine

Breast Pathway Group EC x 4 Paclitaxel x 4 (3-weekly): Epirubicin & Cyclophosphamide x 4 followed by Paclitaxel x 4 (3-weekly) in Early Breast Cancer

Help put out today s gout attack and prevent tomorrow s gout flare with COLCRYS. Use of COLCRYS. Individual results may vary.

Salicylate (Aspirin) Ingestion California Poison Control Background 1. The prevalence of aspirin-containing analgesic products makes

Elements for a public summary

10 Essential Blood Tests PART 1

Abnormal Liver Chemistries. Lauren Myers, MMsc. PA-C Oregon Health and Science University

BC Cancer Protocol Summary for Therapy of Acute Myeloid Leukemia Using azacitidine and SORAfenib

Proceedings of the World Small Animal Veterinary Association Sydney, Australia 2007

BCCA Protocol Summary for the Treatment of Unresectable or Metastatic Melanoma Using Nivolumab

DAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES

Patient Education. Transplant Services. For a liver transplant. Medical Log

Things to never miss in the office. Brett Houston MD FRCPC (PYG-5, hematology) Leonard Minuk MD FRCPC

Nephrotic Syndrome. Sara Alsharhan PharmD candidate, KSU 2014

Warm Autoantibodies in a Patient with Hemophagocytic Lymphohistiocytosis: A Case Report

Calcium (Ca 2+ ) mg/dl

CHEMOTHERAPY PROTOCOL FOR ADMINISTRATION OF VENETOCLAX

Subject ID: I N D # # U A * Consent Date: Day Month Year

Pharmacology Challenges: Managing Statin Myalgia

CARDIOVASCULAR CASE-BASED SMALL GROUP DISCUSSION

IBRUTINIB (IMBRUVICA ) for Chronic Lymphocytic Leukaemia. and Mantel Cell Lymphoma

COMPLICATED DKA SINDHU BHARATHI S STANLEY MEDICAL COLLEGE MD POST GRADUATE

Breast Pathway Group Everolimus in Advanced Breast Cancer

ERROR CORRECTION FORM

YONDELIS (trabectedin) DOSING & ADMINISTRATION GUIDE

Acute Pericarditis as the First Manifestation of Familial Mediterranean Fever: A Possible Relationship with Idiopathic Recurrent Pericarditis

CIBMTR Center Number: CIBMTR Recipient ID: RETIRED. Today s Date: Date of HSCT for which this form is being completed:

Diagnosis delay in familial Mediterranean fever (FMF): Social and gender gaps disclosed

Clinical Toxicology Toxicity of Digitalis Glycosides 5 th Year (Lab 3)

Breast Pathway Group FEC75 (Fluorouracil / Epirubicin / Cyclophosphamide) in Early Breast Cancer

Multi-organ Failure from Fulminant Leptospirosis: A Case Report CSIM 2015: Ted Giles Clinical Case Presentation October 17, 2015

Diseases of liver. Dr. Mohamed. A. Mahdi 4/2/2019. Mob:

Tocilizumab (Actemra )

Nursing Process Focus: Patients Receiving Dextran 40 (Gentran 40)

The role of E148Q in FMF. Elon Pras Institute of Human Genetics Sheba Medical Center

ATORIS 10, 20, 40 mg film-coated tablets

Rini Purwanti Sekretaris PD IPDI Jatim

Documentation Dissection

BC Cancer Protocol Summary for Therapy for Locally Recurrent or Metastatic, RAI-refractory Differentiated Thyroid Cancer Using Lenvatinib

POSTGRADUATE INSTITUTE OF MEDICINE UNIVERSITY OF COLOMBO MP (PAEDIATRICS) EXAMINATION - JULY/AUGUST 2012' PAPER I STRUCTURED ESSAY QUESTIONS

Clinician Blood Panel Results

Panobinostat, Bortezomib and Dexamethasone

Disclosures. How do statins work? Statin Pharmacokinetics 9/12/2013 THERAPEUTIC INTERVENTIONS FOR STATIN INTOLERANT PATIENTS

RISK OF FMF DEVELOPMENT AMONG HETEROZYGOUS PATIENTS IN ARMENIAN POPULATION

Chemistry Reference Ranges and Critical Values

Chemistry Reference Ranges and Critical Values

MHD I SESSION X. Renal Disease

srmp Atorvastatin Medical Valley

Ipilimumab (skin) Indication Advanced (unresectable or metastatic) melanoma in patients who have received prior therapy.

Help put out today s gout attack and prevent tomorrow s gout flare with COLCRYS. Use of COLCRYS. Individual results may vary.

Drafting a Coverage Authorization Request Letter

Routine Clinic Lab Studies

Clinical Study Serum Amyloid A Level in Egyptian Children with Familial Mediterranean Fever

Transcription:

FMF patient with Muscle Pain Soad Haj Yahia Sheba Medical Center Tel Hashomer -Israel

Introduction FMF Familial Mediterranean Fever -Auto inflammatory disease caused by mutations in MEFV gene. -Autosomal recessive -Fever attacks accompanied by abdominal pain (95%) joint pain(75%) Chest pain(40%) erysipelas like rash(5%) Scrotal attacks - inflammation of the tunica vaginalis (5%) Muscle pain attacks with fever,fibromyalgia

FMF Distribution

FMF treatment Colchicine interleukin 1 inhibitors (Anakinra)

Amyloidosis up to 60% Proteinuria Renal failure Dialysis

Case Presentation 61 years old female, FMF since childhood, treated with colchicine 2 mg per day Past Medical History: Behçet's disease MTHFR heterozygous mutation (methylene tetra hydrofolate reductase) Epilepsy

History of present illness : 11 days prior to admission- Gastroscopy (abdominal pain )-erosive gastritis and H pylori infection was suspected and empirical therapy was initiated with Amoxicillin,clarithromycin and omeprazole 10 days prior to her admission -abdominal pain,watery diarrhea,no fever or vomiting 1 day prior to her admission- developed diffuse muscle pain and non specific chest pain. -colonoscopy was done 3 months prior to her admission that was normal.

Physical examination : diffuse muscle tenderness Vital signs : Fever : 36.6 c Pulse : 84 bpm BP : 150/88 O2 saturation : 96% Room air.

Lab Results Test Result Test Result ALT (IU/l) 89 (7-45) CBC (K/microL) 3.6 (4-10.8) Alkaline Phos. (IU/l) 127 (45-115) Neutrophils 70% Bilirubin (mg/dl) 0.9 (0.1-1.1) Platelets (K/microL) 130 (130-440) LDH(IU/l) 254 (100-260) Na+ (meq/l) 137 (136-148) CRP (mg/l) 1.3 (<0.08-5) K+ (meq/l) 3.2 (3.5-5.2) Troponin (micg/l) negative Creatinine (mg/dl) 0.7 (0.6-0.9) Urine dipstick Normal Phosphorus (mg/dl) 2.2 (2-4) CPK (IU/l) 400 (0-170) Blood gases --- AST (IU/l) 81 (7-40)

Diagnosis?

Diagnosis : Clarithromycin induced colchicine toxicity

Manifested with : Abdominal pain Diarrhea Muscle pain (Rhabdomyolysis ) Leukopenia Abnormal liver function tests

FMF severity according to ADAMs score Mild Symptoms of colchicine toxicity Diarrhea, abdominal pain and myalgia Reason of receiving Clarithromycin H PYLORI infection Colchicine dose Age Gender 2 mg 61 Female Moderate Myalgia, vomiting and diarrhea H PYLORI infection 1.5 mg 36 Female Moderate Diarrhea and muscle pain H PYLORI infection 1.5 mg 71 Female Severe Diarrhea and muscle pain H PYLORI infection 2.5 mg 41 Female Severe Vomiting diarrhea and general weakness H PYLORI infection 2.5 mg 24 Female

Past medical History Behçet's disease (3) Hypothyroidism (2) Hypertension (2) MGUS monoclonal gammopathy of undetermined significance (1)

Patient Number Lab results Blood Gases CBC CPK LFT )LDH GOT( KFT electrolytes 1 normal normal 400- elevated 2 normal normal 3624- markdly elevated elevated elevated Hypokalemia normal 3 normal Mild leukopenia 1036 Markdly elevated elevated Hypokalemia 4 normal normal elevated elevated normal 5 normal normal elevated elevated normal 6 normal leukopenia 6277 Markdly elevated elevated Hypokalemia,Hyponatremia

Management -Admission -Hydration -Discontinuation of colchicine and clarithromycin -following discharge colchicine was continued gradually till reaching the targeted dose.

Colchicine toxicity Overdose Drug to drug interaction

Overdose toxicity of colchicine Symptoms started from 3-5 hours after ingestion burning sensation in the mouth and throat Fever Abdominal pain Vomiting and diarrhea Dehydration electrolyte imbalance acute renal failure hepatic failure rhabdomyolysis multi organ failure Death! No antidote for colchicine No available blood test to check colchicine levels. colchicine Fab antibody solution Colchicine is not secreted throughout dialysis

DRUG TO DRUG INTERACTION -CYT P450 3A4

CLARITHROMYCIN Amiodarone Atazanavir Cyclosporine Erythromycin COLCHICINE CYTOCHROME P450 3A4 statin Variconazole Verapamil Isoniazid Nifedipine

How to diagnose Colchicine toxicity? Clinical : signs and symptoms of toxicity include: diarrhea, myalgia, fatigue, abdominal pain, renal failure, bone marrow suppression(leukopenia and thrombopenia ), abnormal liver enzymes, metabolic acidosis and elevated CPK. Muscle biopsy: basophilic vacuoles at the center of muscle fibers EMG : polyphasic motor unit potentials with low amplitude and short duration indicative of myopathy Colchicine level at blood - not available

Take home message Colchicine toxicity narrow therapeutic index Over diagnosis of H pylori among FMF population high index of suspicion! Awareness among doctors!

Sheba Medical Center Tel Hashomer